Neurotrophic factor-secreting autologous muscle stem cell therapy for the treatment of laryngeal denervation injury

Laryngoscope

Volumn 122, Issue 11, 2012, Pages 2482-2496

  Halum, Stacey L ^a   McRae, Bryan ^a   Bijangi Vishehsaraei, Khadijeh ^a   Hiatt, Kelly ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

laryngeal paralysis; Larynx; muscle stem cells; recurrent laryngeal nerve; vocal fold paralysis

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; LENTIVIRUS VECTOR; NEUROTOXIN; NEUROTROPHIC FACTOR; PLASMID VECTOR; VINCRISTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; FOLLOW UP; GENE TRANSFER; IMMUNOHISTOCHEMISTRY; LARYNGOSCOPY; LARYNX MUSCLE; MALE; MOLECULAR CLONING; MOTONEURON; MUSCLE STEM CELL; NERVE FIBER GROWTH; NONHUMAN; PRIMARY CELL CULTURE; PRIORITY JOURNAL; RAT; RECURRENT LARYNGEAL NERVE INJURY; REINNERVATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CILIARY NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; ELECTROMYOGRAPHY; GENETIC VECTORS; IMMUNOHISTOCHEMISTRY; LARYNGOSCOPY; LENTIVIRUS; MUSCLE CELLS; NERVE GROWTH FACTORS; NERVE REGENERATION; PLASMIDS; RATS; RATS, INBRED F344; RECURRENT LARYNGEAL NERVE INJURIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; VINCRISTINE;

EID: 84867982710     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.23519     Document Type: Article

References (37)

1. Koufman JA, Postma GN, Cummins MM, et al. Vocal fold paresis. Otolaryngol Head Neck Surg 2000; 122: 537-541.
2. Bhattacharyya N, Kotz T, Shapiro J,. Dysphagia and aspiration with unilateral vocal fold immobility: incidence, characterization, and response to surgical treatment. Ann Otol Rhinol Laryngol 2002; 111: 672-679.
3. Crumley RL,. Laryngeal synkinesis revisited. Ann Otol Rhinol Laryngol 2000; 109: 365-371.
4. Woodson GE,. Spontaneous laryngeal reinnervation after recurrent laryngeal nerve or vagus nerve injury. Ann Otol Rhinol Laryngol 2007; 116: 57-65.
5. Vega-Cordova X, Cosenza NM, Helfert RH, Woodson GE,. Neurotrophin expression of laryngeal muscles in response to recurrent laryngeal nerve transection. Laryngoscope 2010; 120: 1591-1596.
6. Nomoto M, Yoshihara T, Kanda T, Kaneko T,. Synapse formation by autonomic nerves in the previously denervated neuromuscular junctions of the feline intrinsic laryngeal muscles. Brain Research 1991; 539: 276-280.
7. Nomoto M, Yoshihara T, Kanda T,. Persistent adrenergic reinnervation of previously denervated muscle in cat. Electron Microsc 1993; 42: 236-239.
8. Hydman J, Mattsson P,. Collateral reinnervation by the superior laryngeal nerve after recurrent laryngeal nerve injury. Muscle Nerve 2008; 38: 1280-1289.
9. van Lith-Bijl JT, Mahieu HF, Stolk RJ, Tonnaer JA, Groenhout C, Konings PN,. Laryngeal abductor function after recurrent laryngeal nerve injury in cats. Arch Otolaryngol Head Neck Surg 1996; 122: 393-396.
10. Crumley RL,. Selective reinnervation of vocal cord adductors in unilateral vocal cord paralysis. Ann Otol Rhinol Laryngol 1984; 93 (4 pt 1): 351-356.
11. Marie JP,. Human bilateral laryngeal reinnervation: implications for transplantation. State of the Art Lecture. Paper presented at: American Laryngological Association Combined Otolaryngologic Sections Meeting (COSM), May 28-29,2009; Phoenix, AZ.
12. Flint PW, Shiotani A, O'Malley BW Jr,. IGF-1 gene transfer into denervated rat laryngeal muscle. Arch Otolaryngol Head Neck Surg 1999; 125: 274-279.
13. Shiotani A, O'Malley BW Jr, Coleman ME, et al. Reinnervation of motor endplates and increased muscle fiber size after human insulin-like growth factor I gene transfer into the paralyzed larynx. Hum Gene Ther 1998; 9: 2039-2047.
14. Nakagawa H, Shiotani A, O'Malley BW, et al. Timing of human insulin-like growth factor-1 gene transfer in reinnervating laryngeal muscle. Laryngoscope 2004; 114: 726-732.
15. Paydarfar JA, Paniello RC,. Functional study of four neurotoxins as inhibitors of post-traumatic nerve regeneration. Laryngoscope 2001; 111: 844-850.
16. Halum SL, Naidu M, Delo DM, et al. Injection of autologous muscle stem cells (myoblasts) for the treatment of vocal fold paralysis: a pilot study. Laryngoscope 2007; 117: 917-922.
17. Halum SL, Hiatt KK, Naidu M, et al. Optimization of autologous muscle stem cell survival in the denervated hemilarynx. Laryngoscope 2008; 118: 1308-1312.
18. McRae BR, Kincaid JC, Illing EA, et al. Local neurotoxins for prevention of laryngeal synkinesis after recurrent laryngeal nerve injury. Ann Otol Rhinol Laryngol 2009; 118: 887-893.
19. Kivell BM, McDonald FJ, Miller JH,. Method for serum-free culture of late fetal and early postnatal rat brainstem neurons. Brain Res Brain Res Protoc 2001; 6: 91-99.
20. McRae BR, Aaron GP, Patel RG, Halum SL,. Dissociated cultures and trophic factor effects on cranial nerve X motoneurons in vitro. Paper presented at: Triological Combined Sections Meeting; February 2010; Orlando, FL.
21. Blits B, Kitay BM, Farahvar A, et al. Lentiviral vector-mediated transduction of neural progenitor cells before implantation into injured spinal cord and brain to detect their migration, deliver neurotrophic factors and repair tissue. Restor Neurol Neurosci 2005; 23: 313-324.
22. Hanawa H, Kelly PF, Nathwani AC, et al. Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hemaopoietic cells from human blood. Mol Ther 2002; 5: 242-251.
23. Sastry L, Xu Y, Johnson T, et al. Certification assays for HIV-1-based vectors: frequent passage of gag sequences without evidence of replication-competent viruses. Mol Ther 2003; 8: 830-839.
24. Hu Y, Leaver SG, Plant GW, et al. Lentiviral-mediated transfer of CNTF to schwann cells within reconstructed peripheral nerve grafts enhances adult retinal ganglion cell survival and axonal regeneration. Mol Ther 2005; 11: 906-915.
25. Koufman JA,., Walker FO,. Laryngeal electromyography in clinical practice: indications, techniques, and interpretation. Phonoscope 1998: 1: 57-70.
26. Kingham PJ, Hughes A, Mitchard L, et al. Effect of neurotrophin-3 on reinnervation of the larynx using the phrenic nerve transfer technique. Eur J Neurosci 2007; 25: 331-340.
27. Raper SE, Chirmule N, Lee FS, et al. Fatal systemic inflammatory response syndrome in an ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 2003; 80: 148-158.
28. Raper SE, Yudkoff M, Chirmule N, et al. A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency. Hum Gene Ther 2002; 13: 163-175.
29. Samulski RJ, Chang LS, Shenk T,. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol 1989; 63: 3822-3828.
30. Chirmule N, Propert KJ, Magosin SA, et al. Immune responses to adenovirus and adeno-associated virus in humans. Gene Ther 1999; 6: 1574-1583.
31. Hacein-Bey-Abina S, Le Deist F, Carlier F, et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 2002; 346: 1185-1193.
32. Hacein-Bey-Abina S, von Kalle C, Schmidt M, et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003; 348: 255-256.
33. Goncalves MA, Holkers M, Cudre-Mauroux C, et al. Transduction of myogenic cells by retargeted dual high-capacity hybrid viral vectors: robust dystrophin synthesis in Duchenne muscular dystrophy muscle cells. Mol Ther 2006; 13: 976-986.
34. Sanudo JR, Maranillo E, Leon X, et al. An anatomical study of anastomoses between the laryngeal nerves. Laryngoscope 1999; 109: 983-987.
35. Sheu JY, Kulhanek DJ, Eckenstein FP,. Differential patterns of ERK and STAT3 phosphorylation after sciatic nerve transection in the rat. Exp Neurol 2000; 166: 392-402.
36. Heumann R, Lindholm D, Bandtlow C, et al. Differential regulation of mRNA encoding nerve growth factor and its receptor in rat sciatic nerve during development, degeneration, and regeneration: role of macrophages. Proc Natl Acad Sci U S A 1987; 84: 8735-8739.
37. Lorenz RR, Hicks DM, Shields RW Jr, et al. Laryngeal nerve function after total laryngeal transplantation. Otolaryngol Head Neck Surg 2004; 131: 1016-1018.